Melio Peptide Systems Inc. Closes Follow On Financing to Accelerate Commercial Deployment of its Antibiotic Replacement Technology for the Fuel Ethanol Industry
June 23, 2021
Vancouver, Canada – June 23, 2021 – Melio Peptide Systems Inc. (“Melio” or “Company”), a privately held biotech company announces the successful close of its C$575,000